Arena Pharmaceuticals Appoints Louis J. Lavigne, Jr. to the Company's Board of Directors

21-Jan-2005

Arena Pharmaceuticals, Inc. announced that it has appointed Louis J. Lavigne, Jr., Executive Vice President and Chief Financial Officer of Genentech, Inc., to its board of directors. Mr. Lavigne adds further depth and expertise to Arena's board.

Mr. Lavigne currently serves as Executive Vice President and Chief Financial Officer of Genentech, Inc., and is on the board of directors of LifeMasters Supported SelfCare, Inc., Kyphon Inc. and BMC Software, Inc. He also serves on Genentech's Executive Committee, is Chairman of Genentech's 401K Plan Committee and is responsible for Genentech's Financial, Corporate Relations and Information Technology groups. Mr. Lavigne joined Genentech in 1982 and was promoted to Controller in 1983. He was promoted again to Vice President in 1986 and then named Chief Financial Officer in 1988. In 1994, Mr. Lavigne was promoted to Senior Vice President and was later promoted to Executive Vice President in 1997. Prior to his tenure at Genentech, Mr. Lavigne held various financial management positions with Pennwalt Corporation, a chemical and pharmaceutical company. Mr. Lavigne holds a bachelor's degree in business administration from Babson College, and a master's degree in business administration from Temple University.

Other news from the department people

Most read news

More news from our other portals

Discover the latest developments in battery technology!